Trial Details
AuthorisedBasic Information
| Clinical ID | c3135 |
|---|---|
| Identifier | EUCTR2012-005644-26-NL |
| Trial Title | Administration of intranvenous ferric carboxymaltose to children with IBD - AFCI |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Anemia in children with Inflammatory Bowel Disease (IBD);Therapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10] |
| Interventions | Trade Name: Ferinject Product Name: ferinject Pharmaceutical Form: Concentrate and solvent for solution for infusion Pharmaceutical form of the placebo: Oral liquid Route of administration of the placebo: Oral use |
Participant Information
| Sponsor | Atrium Medical Centre |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |